Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Kosten

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Cureus|September 8, 2022
Managing Opioid Withdrawal in an Outpatient Setting With Lofexidine or ClonidineJeanne Gripshover, Thomas Kosten
South Dakota Medicine : the Journal of the South Dakota State Medical Association|August 18, 2017
Treating Addiction to Prescription OpioidsXiaofan Li, Thomas Kosten
The American Journal on Addictions|March 30, 2018
CommentaryThomas Kosten, Coreen Domingo
The Journal of Clinical Psychiatry|August 10, 2007
Dual dependency on cocaine and alcohol in opiate addicts: treatment optionsTracie Gardner, Thomas Kosten
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|June 15, 2011
Developing the tools of implementation science in substance use disorders treatment: applications of the consolidated framework for implementation researchJames L Sorensen, Thomas Kosten
Pharmacology & Therapeutics|July 19, 2005
Immunotherapy for the treatment of drug abuseThomas Kosten, S Michael Owens
Addiction (Abingdon, England)|May 20, 2003
Effects of reducing contingency management values on heroin and cocaine use for buprenorphine- and desipramine-treated patientsThomas Kosten, James Poling, Alison Oliveto
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|April 8, 2009
The VA psychiatry-primary care education initiativeRobert M Rohrbaugh, Bradford Felker, Thomas Kosten
The American Journal on Addictions|June 19, 2004
Depression predicts higher rates of heroin use on desipramine with buprenorphine than with methadoneThomas Kosten, Jean Falcioni, Alison Oliveto, et al.
Expert Review of Vaccines|March 19, 2013
Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuseStephen Brimijoin, Xiaoyun Shen, Frank Orson, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Cureus|September 8, 2022
Managing Opioid Withdrawal in an Outpatient Setting With Lofexidine or ClonidineJeanne Gripshover, Thomas Kosten
South Dakota Medicine : the Journal of the South Dakota State Medical Association|August 18, 2017
Treating Addiction to Prescription OpioidsXiaofan Li, Thomas Kosten
The American Journal on Addictions|March 30, 2018
CommentaryThomas Kosten, Coreen Domingo
The Journal of Clinical Psychiatry|August 10, 2007
Dual dependency on cocaine and alcohol in opiate addicts: treatment optionsTracie Gardner, Thomas Kosten
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|June 15, 2011
Developing the tools of implementation science in substance use disorders treatment: applications of the consolidated framework for implementation researchJames L Sorensen, Thomas Kosten
Pharmacology & Therapeutics|July 19, 2005
Immunotherapy for the treatment of drug abuseThomas Kosten, S Michael Owens
Addiction (Abingdon, England)|May 20, 2003
Effects of reducing contingency management values on heroin and cocaine use for buprenorphine- and desipramine-treated patientsThomas Kosten, James Poling, Alison Oliveto
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|April 8, 2009
The VA psychiatry-primary care education initiativeRobert M Rohrbaugh, Bradford Felker, Thomas Kosten
The American Journal on Addictions|June 19, 2004
Depression predicts higher rates of heroin use on desipramine with buprenorphine than with methadoneThomas Kosten, Jean Falcioni, Alison Oliveto, et al.
Expert Review of Vaccines|March 19, 2013
Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuseStephen Brimijoin, Xiaoyun Shen, Frank Orson, et al.
Pageof 6